Contact Us


Name (required)

Company (required)

Email (required)
(We will keep your email completely private)

Phone Number (required)

Your Message

Stay Up To Date With All Developing News From WDPrx: May 2020

WDPrx – Woodfield Pharmaceutical, LLC is a proven and reliable CMO pharma partner specializing in oral solutions, liquid solutions, suspensions and semi-solids managing early-stage development, R+D, technology transfer, pharmaceutical formulation and development, exhibit batches, ANDA and NDA regulatory support.

Our schedule over the previous month was filled with ongoing and new projects for multiple clients  as operations continue with appropriate safety measures for the health of our employees and patients.

TRENDS IN LIQUID MANUFACTURING

Monthly WDPrx operations, updates and technology news photo of temperature regulation in liquid solutions.

Multiple vat volumes produce test batches and full-scale production for all stages of development and commercialization.

Recent WDPrx projects include formulating and producing a nutritional supplement with an innovative delivery mechanism and manufacturing a cough and cold item bundled with an allergy and sinus medication for a major brand name.

GOVERNMENT CONTRACTS

Monthly WDPrx operations, updates and technology news photo of quality assurance reviewing products.

Production at WDPrx accommodates a wide range of primary packaging and delivery mechanisms.

Our production facility is increasing activity from government contractors to manufacture OTC items in large quantities to maintain assurance of continued supply for future needs.

R&D ACTIVITY

R+D services support clients with development, formulation and testing of new medications.

The WDPrx R&D team is managing multiple new projects to support customer ANDA filings.

TECHNOLOGY TRANSFER

Monthly WDPrx operations, updates and technology news photo of a WDPrx team of scientists.

Communication and interaction between teams allows for successful projects at WDPrx.

A prescription drug product is ready for scale-up to commercial manufacturing after completing full technology transfer to WDPrx.